Nucala subcutaneous injection 40mg syringe for children (YJ code: 2290401G3029, standard: 40mg0.4mL 1 cylinder) is a GlaxoSmithKline medication containing Mepolizumab (genetical recombination). It is approved for children aged 6 to 11 years old with severe eosinophilic asthma and can be administered by a healthcare provider or a caregiver.
Nucala subcutaneous injection 40mg syringe for children
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →